Financhill
Back

Helmerich & Payne Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
34

HP
Helmerich & Payne

Last Price:
39.30
Seasonality Move:
-0.12%
Sell
38

ITCI
Intra-Cellular Therapies

Last Price:
66.31
Seasonality Move:
-6.93%
Sell
34
Helmerich & Payne (HP) is a Sell

Is Helmerich & Payne a Buy, Sell or Hold?

  • The current Helmerich & Payne [HP] share price is $38.74. The Score for HP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • HP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HP Stock Price Chart

What is Helmerich & Payne's stock price today?

  • The Helmerich & Payne share price today is $38.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HP is experiencing slight selling pressure.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $65.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.

HP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 43.41 Sell
Chaikin Money Flow: -100686 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.26 - 41.08) Sell
Bollinger Bands (100): (36.08 - 41.52) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.32 Sell
Relative Strength Index (14 RSI): 41.48 Sell
Chaikin Money Flow: 421582 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.45 - 74.29) Sell
Bollinger Bands (100): (65.99 - 72.19) Sell

HP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.72 Buy
20-day SMA: 39.27 Sell
50-day SMA: 40.7 Sell
200-day SMA: 39.56 Sell
8-day EMA: 38.67 Buy
20-day EMA: 39.25 Sell
50-day EMA: 39.76 Sell
200-day EMA: 39.35 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.78 Sell
20-day SMA: 69.19 Sell
50-day SMA: 68.67 Sell
200-day SMA: 62.8 Buy
8-day EMA: 66.34 Sell
20-day EMA: 68 Sell
50-day EMA: 68.71 Sell
200-day EMA: 64.66 Buy

Helmerich & Payne Earnings Growth & HP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.76 per share, and an increase next year of $0.34 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.

Helmerich & Payne Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):